Kaken Pharmaceutical Market Cap

Kaken Pharmaceutical has a market cap or net worth of 162.27 billion as of March 6, 2026. Its market cap has increased by 0.79% in one year.

Market Cap

162.27B

Enterprise Value

120.28B

Revenue

75.66B

Ranking

n/a

PE Ratio

n/a

Stock Price

4,285.00

Market Cap Chart

Since March 26, 1993, Kaken Pharmaceutical's market cap has increased from 118.38B to 162.27B, an increase of 37.07%. That is a compound annual growth rate of 0.96%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	163.02B	7.22%
Dec 30, 2025	152.04B	-11.05%
Dec 30, 2024	170.93B	34.53%
Dec 29, 2023	127.05B	-12.84%
Dec 30, 2022	145.77B	-8.45%
Dec 30, 2021	159.22B	3.78%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Kissei Pharmaceutical	191.09B
Mochida Pharmaceutical	130.81B
Towa Pharmaceutical	206.76B
Sawai Group Holdings	256.32B
KYORIN Pharmaceutical	95.66B
Zeria Pharmaceutical	95.21B
Tsumura & Co.	292.96B
Toho Holdings	313.67B

Market Cap Rankings